GLS1 inhibitors for treating disease
US11958849B2 · kind B2 · utility
2Cited by
18References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2022 |
| Grant date | Apr 16, 2024 |
| Priority date | — |
| Expiry date | Apr 25, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I: Methods of inhibition GLS1 activity in a human or animal subject are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.